The European Medicines Agency (EMA) approved the AstraZeneca COVID-19 vaccine as a preventative measure against the disease on Jan. 29 without any restrictions, despite concerns from German experts who say the vaccine lacks sufficient data on people 65 and older. This is the third COVID vaccine approved by the EMA—the European Union’s drug regulator similar to the Food and Drug Association in the United States— following those made by Moderna and Pfizer. The EMA said that the vaccine will give protection to people older than 55 although there weren’t “enough results” to show “how well the vaccine will work in this group.” “However, protection is expected, given that an immune response is seen in this age group and based on experience with other vaccines,” the EMA said in a statement. “As there is reliable information on safety in this population, EMA’s scientific experts considered that the vaccine can be used …